Medicine

HIV protection through PrEP in cisgender females

.RESEARCH EMPHASIZE.06 August 2024.

A big randomized measured trial along with cisgender women highlights the difficulties of faithfulness to a regular dental preexposure prevention program and also illustrates that twice-yearly injection of lenacapavir can sustain helpful HIV deterrence degrees over 6 months.